An IIT solution to 'expensive' biotechnologyTrastuzumab, a drug developed through bio-engineering, currently has a maximum retail price of Rs 52,000-58,602 for a 440 mg vial, dependin...
MSD launches blockbuster cancer drug Keytruda in IndiaDCGI gave MSD permission to market Keytruda in June 2016, according to minutes of the regulator’s Subject Expert Committee on oncology and ...
Roche vs Indian Pharma: The battle for a cheaper cancer drugThe companies in the thick of it are Roche, a $51 billion Swiss pharma major, and Biocon, the Bengaluru-based company led by India’s first ...